GLS-1200 Topical Nasal Spray to Prevent Sinusitis After Endoscopic Sinus Surgery
Status:
Not yet recruiting
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
This clinical trial will evaluate the safety, tolerability and effectiveness of GLS-1200
nasal spray in addition to the standard of care after endoscopic sinus surgery in people with
chronic sinusitis.